Abstract Views
PDF Download
Research Articles

The incidence of preeclampsia based on maternal characteristics: a cohort study

, ,
Pages 121-132


Preeclampsia is one of the leading causes of maternal mortality. Research on the characteristics of mothers who are at risk for preeclampsia at the first pregnancy visit is important to prevent the incidence of preeclampsia. This study aims to determine the incidence of preeclampsia based on maternal characteristics. A cohort study design was used to determine the effect of maternal characteristics on the incidence of preeclampsia Sample was pregnant women who made their first pregnancy visit. The analysis was chi-square. The results showed that the factors that were significantly associated with the occurrence of preeclampsia were: primigravida (P-value: 0.00), family history of preeclampsia (P-value: 0.00), occupation (P-value:0.04), and insurance ownership (P-value:0.03). A risk assessment of preeclampsia in pregnant women can be carried out at the time of the first antenatal visit.

There is no Figure or data content available for this article


  • Firoz T, Sanghvi H, Merialdi M, Von Dadelszen P. Pre-Eclampsia in Low and Middle Income Countries. Best Pract Res Clin Obstet Gynaecol [Internet]. 2011;25(4):537–48. Available from: http://dx.doi.org/10.1016/j.bpobgyn.2011.04.002
  • Milne, F. Redman C WJ et al. The Pre-Eclampsia Community Guideline (PRECOG): How to Screen for and Detect Onset of Pre-eclampsia in the Community. Bmj [Internet]. 2005;330(7491):576–80. Available from: http://www.bmj.com/cgi/doi/10.1136/bmj.330.7491.576
  • Thangaratinam S, Allotey J, Marlin at al. Development and Validation of Prediction Models for Risks of Complications in Early-onset Pre-eclampsia (PREP): A Prospective Cohort Study. Health Technol Assess (Rockv). 2017;21(18):1–99.
  • Indonesiaon Health Ministry. Indonesian Health Profiles 2016 [Internet]. Kementrian Kesehatan RI; 2017. p. 431. Available from: https://www.kemkes.go.id/resources/download/pusdatin/profil-kesehatan-indonesia/Profil-Kesehatan-Indonesia-tahun-2017.pdf
  • Central Java Health office. Health Profile of Central Java [Internet]. Office, Central Java Provincial Health. 2015. p. 48–9. Available from: dinkesjatengprov.go.id/v2015/dokumen/profil2015/Profil_2015_fix.pdf
  • Ouasmani F, Engeltjes B, Haddou Rahou B, Belayachi O, Verhoeven C. Knowledge of hypertensive disorders in pregnancy of Moroccan women in Morocco and in the Netherlands: A qualitative interview study. BMC Pregnancy Childbirth. 2018;18(1):1–11.
  • Tue SM. A Systematic Review Of Treatment and Management of Preeclampsia and Eclampsia In Nigeria. 2016;(March):327–36.
  • von Dadelszen P. PRE-EMPT ( PRE-eclampsia-Eclampsia Monitoring , Prevention and Treatment ): A Low and Middle Income Country Initiative to Reduce The Global Burden of Maternal , Fetal and Infant Death and Desease Related to Pre-eclampsia. Pregnancy Hypertens An Int J Womens Cardiovasc Heal. 2013;
  • Thangaratinam S, Langenveld J, Mol BW, Khan KS. Prediction and Primary Prevention ofPpre-eclampsia. Best Pract Res Clin Obstet Gynaecol [Internet]. 2011;25(4):419–33. Available from: http://dx.doi.org/10.1016/j.bpobgyn.2011.02.008
  • Kemenkes RI. Profil Kesehatan Indonesia 2018 Kemenkes RI. (2019). [Internet]. 2019. 207 p. Available from: http://www.depkes.go.id/resources/download/pusdatin/profil-kesehatan-indonesia/Data-dan-Informasi_Profil-Kesehatan-Indonesia-2018.pdf
  • Health Office Cilacap District. Health Profile of Cilacap District 2014. 2014. 155 p.
  • Burton GJ, Redman CW, Roberts JM, Moffett A. Pre-eclampsia: pathophysiology and clinical implications. BMJ. 2019;366:1–15.
  • Amaral LM, Wallace K, Owens M, LaMarca B. Pathophysiology and Current Clinical Management of Preeclampsia. Curr Hypertens Rep. 2017;19(8):19–21.
  • Gathiram P, Moodley J. Pre-eclampsia: Its pathogenesis and pathophysiolgy. Cardiovasc J Afr. 2016;27(2):71–8.
  • Martínez-Varea A, Pellicer B, Perales-Marín A, Pellicer A. Relationship between maternal immunological response during pregnancy and onset of preeclampsia. J Immunol Res. 2014;2014.
  • Ingleby E. Research methods in education. Vol. 38, Professional Development in Education. 2012. 507-509 p.
  • Luo ZC, An N, Xu HR, Larante A, Audibert F, Fraser WD. The Effects and Mechanisms of Primiparity on The Risk of Pre-eclampsia: A systematic Review. Paediatr Perinat Epidemiol. 2007;21(SUPPL. 1):36–45.
  • Kenny LC, Black MA, Poston L, Taylor R, Myers JE, Baker PN, et al. Early Pregnancy Prediction of Preeclampsia in Nulliparous Women, Combining Clinical Risk and Biomarkers: The Screening for Pregnancy Endpoints (SCOPE) international cohort study. Hypertension. 2014;64(3):644–52.
  • Myatt L, Ph D, Clifton RG, Roberts JM, Catherine Y, Hauth JC, et al. First-Trimester Prediction of Preeclampsia in Low-Risk Nulliparous Women. Obstet Gynecol. 2013;119(6):1234–42.
  • Bdolah Y, Elchalal U, Natanson-Yaron S, Yechiam H, Bdolah-Abram T, Greenfield C, et al. Relationship between nulliparity and preeclampsia may be explained by altered circulating soluble fms-like tyrosine kinase 1. Hypertens Pregnancy. 2014;33(2):250–9.
  • Luo ZC, An N, Xu HR, Larante A, Audibert F, Fraser WD. The effects and mechanisms of primiparity on the risk of pre-eclampsia: A systematic review. Paediatr Perinat Epidemiol. 2007;21(SUPPL. 1):36–45.
  • Lokki AI, Heikkinen-Eloranta JK, Laivuori H. The immunogenetic conundrum of preeclampsia. Front Immunol. 2018;9(NOV):1–8.
  • Grum T, Seifu A, Abay M, Angesom T, Tsegay L. Determinants of pre-eclampsia/Eclampsia among women attending delivery Services in Selected Public Hospitals of Addis Ababa, Ethiopia: A case control study. BMC Pregnancy Childbirth. 2017;17(1):1–7.
  • McDonald JC. What we know and what we do not know. Radiat Prot Dosimetry. 2005;113(2):127–8.
  • Cormick G, Betrán AP, Ciapponi A, Hall DR, Hofmeyr GJ. Inter-Pregnancy Interval and Risk of Recurrent Pre-Eclampsia: Systematic Review and Meta-analysis. Reprod Health [Internet]. 2016;13(1). Available from: http://dx.doi.org/10.1186/s12978-016-0197-x
  • Skjærven R, Wilcox AJ, Lie RT. The interval between pregnancies and the risk of preeclampsia. N Engl J Med. 2002;346(1):33–8.
  • Harutyunyan A, Armenian H, Petrosyan V. Interbirth interval and history of previous preeclampsia: a case-control study among multiparous women. BMC Pregnancy Childbirth. 2013;13.
  • Howe L, Hammer E, Badger G, Bernstein IM. Effect of Pregnancy Interval on Second Pregnancy Blood Pressure Following Prior Preeclampsia. Reprod Sci. 2018;25(5):727–32.
  • WHO. Report of a WHO Technical Consultation on Birth Spacing [Internet]. Vol. 13, Report of a WHO Technical Consultation on Birth Spacing. 2005. 1-44 p. Available from: http://www.who.int/maternal_child_adolescent/documents/birth_spacing.pdf
  • Chen I, Jhangri GS, Chandra S. Relationship between interpregnancy interval and congenital anomalies. Am J Obstet Gynecol [Internet]. 2014;210(6):564.e1-564.e8. Available from: http://dx.doi.org/10.1016/j.ajog.2014.02.002
  • Zhang J. Partner change, birth interval and risk of pre-eclampsia: A paradoxical triangle. Paediatr Perinat Epidemiol. 2007;21(SUPPL. 1):31–5.
  • Sanga LA, Mtuy T, Philemon RN, Mahande MJ. Inter-pregnancy interval and associated adverse maternal outcomes among women who delivered at Kilimanjaro Christian Medical Centre in Tanzania, 2000-2015. PLoS One. 2020;15(2):1–15.
  • Trogstad LIS, Eskild A, Magnus P, Samuelsen SO, Nesheim BI. Changing paternity and time since last pregnancy; the impact on pre-eclampsia risk. A study of 547 238 women with and without previous pre-eclampsia. Int J Epidemiol. 2001;30(6):1317–22.
  • WHO. Preventing Early Pregnancy and Poor Reproductive Outcomes Among Adolescents in Developing Countries. Vol. 69, WHO. 2011. 3-11 p.
  • Demirci O, Y?lmaz E, Tosun Ö, Kumru P, Ar?nkan A, Mahmuto?lu D, et al. Effect of young maternal age on obstetric and perinatal outcomes: Results from the tertiary center in Turkey. Balkan Med J. 2016;33(3):344–9.
  • Lamminpää R, Vehviläinen-Julkunen K, Gissler M, Heinonen S. Preeclampsia complicated by advanced maternal age: a registry-based study on primiparous women in Finland 1997-2008. BMC Pregnancy Childbirth. 2012;12:2–6.
  • Chan TF, Tung YC, Wang SH, Lee CH, Lin CL, Lu PY. Trends in the incidence of pre-eclampsia and eclampsia in Taiwan between 1998 and 2010. Taiwan J Obstet Gynecol [Internet]. 2015;54(3):270–4. Available from: http://dx.doi.org/10.1016/j.tjog.2013.06.021
  • Dietl A, Cupisti S, Beckmann MW, Schwab M, Zollner U. Pregnancy and Obstetrical Outcomes in Women over 40 Years of Age. Geburtshilfe Frauenheilkd. 2015;75(8):827–32.
  • Salihu H, Shumpert N, Slay M, Kirby RS AlG. Childbearing beyond maternal age 50 and fetal outcomes in the United States. Obstet Gynecol. 2003;102(5):1006–14.
  • El-Gilany AH, Hammad S. Obstetric outcomes of teenagers and older mothers: Experience from Saudi Arabia. Int J Collab Res Intern Med Public Heal. 2012;4(6):901–9.
  • Cavazos-rehg PA, Krauss MJ, Spitznagel EL, Bommarito K, Madden T, Olsen MA, et al. Maternal age and risk of labor and delivery complications. 2016;19(6):1202–11.
  • Mrema D, Lie RT, Østbye T, Mahande MJ, Daltveit AK. The association between pre pregnancy body mass index and risk of preeclampsia: A registry based study from Tanzania. BMC Pregnancy Childbirth. 2018;18(1):1–8.
  • O’Brien TE, Ray JG CW. Maternal Body Mass Index and The Risk of Preeclampsia. A Syst Overv. 2003;14(Epidemiology):368–74.
  • Motedayen M, Rafiei M, Tavirani MR, Sayehmiri K, Dousti M. The relationship between body mass index and preeclampsia: A systematic review and meta-analysis. Int J Reprod Biomed. 2019;17(7):465–74.
  • Robillard PY, Dekker G, Scioscia M, Bonsante F, Iacobelli S, Boukerrou M, et al. Increased BMI has a linear association with late-onset preeclampsia: A population-based study. PLoS One. 2019;14(10):1–14.
  • Shah TJ, Leik CE, Walsh SW. Neutrophil infiltration and systemic vascular inflammation in obese women. Reprod Sci. 2010;17(2):116–24.
  • Weil BR, Westby CM, van Guilder GP, Greiner JJ, Stauffer BL, de Souza CA. Enhanced endothelin-1 system activity with overweight and obesity. Am J Physiol - Hear Circ Physiol. 2011;301(3).
  • Boyd HA, Tahir H, Wohlfahrt J, Melbye M. Associations of personal and family preeclampsia historywith the risk of early-, intermediate- and late-onset preeclampsia. Am J Epidemiol. 2013;178(11):1611–9.
  • Haram K, Mortensen JH, Nagy B. Genetic aspects of preeclampsia and the hellp syndrome. J Pregnancy. 2014;2014.
  • Bezerra PCFM, Leão MD, Queiroz JW, Melo EMD, Pereira FVM, Nóbrega MH, et al. Family history of hypertension as an important risk factor for the development of severe preeclampsia. Acta Obstet Gynecol Scand. 2010;89(5):612–7.
  • Feeney JG, Scott JS. Pre-eclampsia and changed paternity. Eur J Obstet Gynecol Reprod Biol. 1980;11(1):35–8.
  • Klonoff-Cohen HS. An epidemiologic study of contraception and preeclampsia. JAMA J Am Med Assoc. 1989;262(22):3143–7.
  • Li DK, Wi S. Changing paternity and the risk of preeclampsia/eclampsia in the subsequent pregnancy. Am J Epidemiol. 2000;151(1):57–62.
  • Tubbergen P, Lachmeijer AMA, Althuisius SM, Vlak MEJ, Van Geijn HP, Dekker GA. Change in paternity: A risk factor for preeclampsia in multiparous women? J Reprod Immunol. 1999;45(1):81–8.
  • Robillard PY, Hulsey TC, Perianin J, Janky E, Miri EH, Papiernik E. Association of pregnancy-induced hypertension with duration of sexual cohabitation before conception. ACOG Curr J Rev. 1995;8(2):20.
  • Li DK, Wi S. Changing Paternity and the Risk of Preeeclampsia/Eclampsia in the Subsequent Pregnancy. Am J Epidemiol. 2000;151(1):57–62.
  • Wikström AK, Gunnarsdóttir J, Cnattingius S. The paternal role in pre-eclampsia and giving birth to a small for gestational age infant; a population-based cohort study. BMJ Open. 2012;2(4):1–9.
  • Yoneda N, Shiozaki A, Miura K, Yonezawa R, Takemura K, Yoneda S, et al. A triploid partial mole placenta from paternal isodisomy with a diploid fetus derived from one sperm and one oocyte may have caused angiogenic imbalance leading to preeclampsia-like symptoms at 19 weeks of gestation. Placenta [Internet]. 2013;34(7):631–4. Available from: http://dx.doi.org/10.1016/j.placenta.2013.03.015
  • Duncan BB. Waist circumference in the prediction of obesity-related adverse pregnancy outcomes Circunferência da cintura na predição de desfechos adversos da gestação relacionados à obesidade. Methods. 2007;23(2):391–8.
  • Zhu S, Wang Z, Heshka S, Heo M, Faith MS, Heymsfield SB. Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey?: clinical action thresholds 1 – 3. 2002;
  • Maria E, Dantas DM, Venicio F, Pereira M, Queiroz JW, Luis D, et al. Preeclampsia is associated with increased maternal body weight in a northeastern Brazilian population. BMC Pregnancy Childbirth. 2013;13.
  • Feldstein CA, Akopian M, Olivieri AO, Kramer AP, Nasi M, Garrido D. A comparison of body mass index and waist-to-hip ratio as indicators of hypertension risk in an urban Argentine population: A hospital-based study. Nutr Metab Cardiovasc Dis. 2005;15(4):310–5.
  • Sattar N, Clark P, Holmes A, Lean MEJ, Walker I, Greer IA. Antenatal waist circumference and hypertension risk. Obstet Gynecol. 2001;97(2):268–71.
There is no Supplemental content for this article.

How to Cite This

Johariyah, J., Nurdiati, D. S. ., & Widyawati, W. (2022). The incidence of preeclampsia based on maternal characteristics: a cohort study. Jurnal Kesehatan Ibu Dan Anak, 15(2), 121–132. https://doi.org/10.29238/kia.v15i2.1093

Article Metrics

Download Statistics


Download data is not yet available.

Other Statistics

Verify authenticity via CrossMark

Copyright and Permissions

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Publishing your paper with Jurnal Kesehatan Ibu dan Anak means that the author or authors retain the copyright in the paper. Jurnal Kesehatan Ibu dan Anak granted an exclusive reuse license by the author(s), but the author(s) are able to put the paper onto a website, distribute it to colleagues, give it to students, use it in your thesis etc, even commercially. The author(s) can reuse the figures and tables and other information contained in their paper published by Jurnal Kesehatan Ibu dan Anak in future papers or work without having to ask anyone for permission, provided that the figures, tables or other information that is included in the new paper or work properly references the published paper as the source of the figures, tables or other information, and the new paper or work is not direct at the private monetary gain or commercial advantage.

Jurnal Kesehatan Ibu dan Anak provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. This journal is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets others remix, transform, and build upon the material for any purpose, even commercially.

Jurnal Kesehatan Ibu dan Anak Open Access articles are distributed under this Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA). Articles can be read and shared for All purposes under the following conditions:

  • BY: You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • SA:  If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.

Data Availability